nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.431	1	CbGbCtD
Thioridazine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0316	0.11	CbGeAlD
Thioridazine—Trismus—Riluzole—amyotrophic lateral sclerosis	0.0283	0.112	CcSEcCtD
Thioridazine—Priapism—Riluzole—amyotrophic lateral sclerosis	0.0196	0.0771	CcSEcCtD
Thioridazine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0132	0.0458	CbGeAlD
Thioridazine—HTR7—pons—amyotrophic lateral sclerosis	0.013	0.0452	CbGeAlD
Thioridazine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0495	CcSEcCtD
Thioridazine—DRD1—nerve—amyotrophic lateral sclerosis	0.0108	0.0375	CbGeAlD
Thioridazine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0424	CcSEcCtD
Thioridazine—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00946	0.0373	CcSEcCtD
Thioridazine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00935	0.0368	CcSEcCtD
Thioridazine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00935	0.0368	CcSEcCtD
Thioridazine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00888	0.035	CcSEcCtD
Thioridazine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00867	0.0301	CbGeAlD
Thioridazine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00822	0.0285	CbGeAlD
Thioridazine—HTR2A—pons—amyotrophic lateral sclerosis	0.00813	0.0282	CbGeAlD
Thioridazine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00782	0.0308	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00728	0.0287	CcSEcCtD
Thioridazine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00693	0.0241	CbGeAlD
Thioridazine—HTR7—nerve—amyotrophic lateral sclerosis	0.00676	0.0235	CbGeAlD
Thioridazine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0067	0.0264	CcSEcCtD
Thioridazine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0257	CcSEcCtD
Thioridazine—DRD2—nerve—amyotrophic lateral sclerosis	0.00639	0.0222	CbGeAlD
Thioridazine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00636	0.0221	CbGeAlD
Thioridazine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00594	0.0206	CbGeAlD
Thioridazine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00593	0.0234	CcSEcCtD
Thioridazine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0222	CcSEcCtD
Thioridazine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0213	CcSEcCtD
Thioridazine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00541	0.0188	CbGeAlD
Thioridazine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0054	0.0213	CcSEcCtD
Thioridazine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.0053	0.0184	CbGeAlD
Thioridazine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00516	0.0203	CcSEcCtD
Thioridazine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00506	0.0176	CbGeAlD
Thioridazine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00494	0.0195	CcSEcCtD
Thioridazine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00488	0.017	CbGeAlD
Thioridazine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00479	0.0166	CbGeAlD
Thioridazine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00468	0.0184	CcSEcCtD
Thioridazine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00464	0.0161	CbGeAlD
Thioridazine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00424	0.0167	CcSEcCtD
Thioridazine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00421	0.0146	CbGeAlD
Thioridazine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00416	0.0164	CcSEcCtD
Thioridazine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00387	0.0153	CcSEcCtD
Thioridazine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0151	CcSEcCtD
Thioridazine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0038	0.015	CcSEcCtD
Thioridazine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00378	0.0149	CcSEcCtD
Thioridazine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0037	0.0146	CcSEcCtD
Thioridazine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00361	0.0125	CbGeAlD
Thioridazine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0134	CcSEcCtD
Thioridazine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0133	CcSEcCtD
Thioridazine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0033	0.013	CcSEcCtD
Thioridazine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00329	0.013	CcSEcCtD
Thioridazine—HTR6—nervous system—amyotrophic lateral sclerosis	0.00327	0.0114	CbGeAlD
Thioridazine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00326	0.0129	CcSEcCtD
Thioridazine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0127	CcSEcCtD
Thioridazine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00316	0.011	CbGeAlD
Thioridazine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00315	0.0124	CcSEcCtD
Thioridazine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00315	0.0109	CbGeAlD
Thioridazine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00304	0.0105	CbGeAlD
Thioridazine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.003	0.0118	CcSEcCtD
Thioridazine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00293	0.0116	CcSEcCtD
Thioridazine—HTR7—brainstem—amyotrophic lateral sclerosis	0.0029	0.0101	CbGeAlD
Thioridazine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00289	0.0114	CcSEcCtD
Thioridazine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00288	0.00998	CbGeAlD
Thioridazine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.0028	0.00972	CbGeAlD
Thioridazine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00278	0.011	CcSEcCtD
Thioridazine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00274	0.00952	CbGeAlD
Thioridazine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0105	CcSEcCtD
Thioridazine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00261	0.00906	CbGeAlD
Thioridazine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00251	0.00873	CbGeAlD
Thioridazine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00251	0.00872	CbGeAlD
Thioridazine—HTR6—brain—amyotrophic lateral sclerosis	0.0025	0.00868	CbGeAlD
Thioridazine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00249	0.0098	CcSEcCtD
Thioridazine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00243	0.00844	CbGeAlD
Thioridazine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00234	0.00813	CbGeAlD
Thioridazine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0091	CcSEcCtD
Thioridazine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00224	0.00779	CbGeAlD
Thioridazine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00846	CcSEcCtD
Thioridazine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00839	CcSEcCtD
Thioridazine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00838	CcSEcCtD
Thioridazine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00833	CcSEcCtD
Thioridazine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00202	0.00702	CbGeAlD
Thioridazine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.002	0.0079	CcSEcCtD
Thioridazine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00199	0.00692	CbGeAlD
Thioridazine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00197	0.00685	CbGeAlD
Thioridazine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00196	0.00681	CbGeAlD
Thioridazine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00189	0.00656	CbGeAlD
Thioridazine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00189	0.00655	CbGeAlD
Thioridazine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00189	0.00655	CbGeAlD
Thioridazine—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.00188	0.00654	CbGeAlD
Thioridazine—DRD1—brain—amyotrophic lateral sclerosis	0.00186	0.00645	CbGeAlD
Thioridazine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00182	0.00632	CbGeAlD
Thioridazine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00181	0.00628	CbGeAlD
Thioridazine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.0018	0.00626	CbGeAlD
Thioridazine—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.00168	0.00583	CbGeAlD
Thioridazine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00165	0.00572	CbGeAlD
Thioridazine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00159	0.00552	CbGeAlD
Thioridazine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00153	0.00532	CbGeAlD
Thioridazine—HTR7—nervous system—amyotrophic lateral sclerosis	0.00152	0.00528	CbGeAlD
Thioridazine—Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.0015	0.651	CrCbGaD
Thioridazine—CHRM2—brain—amyotrophic lateral sclerosis	0.0015	0.0052	CbGeAlD
Thioridazine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.0015	0.0052	CbGeAlD
Thioridazine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00148	0.00515	CbGeAlD
Thioridazine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00147	0.00509	CbGeAlD
Thioridazine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00146	0.00508	CbGeAlD
Thioridazine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00145	0.00504	CbGeAlD
Thioridazine—HTR2C—brain—amyotrophic lateral sclerosis	0.00144	0.00501	CbGeAlD
Thioridazine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00144	0.00499	CbGeAlD
Thioridazine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.00143	0.00497	CbGeAlD
Thioridazine—KCNH2—nervous system—amyotrophic lateral sclerosis	0.00142	0.00492	CbGeAlD
Thioridazine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00141	0.0049	CbGeAlD
Thioridazine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00138	0.0048	CbGeAlD
Thioridazine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00138	0.00479	CbGeAlD
Thioridazine—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00473	CbGeAlD
Thioridazine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00135	0.0047	CbGeAlD
Thioridazine—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.00133	0.00463	CbGeAlD
Thioridazine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00132	0.00459	CbGeAlD
Thioridazine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00129	0.00449	CbGeAlD
Thioridazine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00126	0.00438	CbGeAlD
Thioridazine—HTR1A—brain—amyotrophic lateral sclerosis	0.00122	0.00422	CbGeAlD
Thioridazine—HTR7—brain—amyotrophic lateral sclerosis	0.00116	0.00403	CbGeAlD
Thioridazine—HRH1—nervous system—amyotrophic lateral sclerosis	0.00113	0.00394	CbGeAlD
Thioridazine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00112	0.00391	CbGeAlD
Thioridazine—ADRA1A—brain—amyotrophic lateral sclerosis	0.00112	0.00389	CbGeAlD
Thioridazine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00111	0.00387	CbGeAlD
Thioridazine—DRD2—brain—amyotrophic lateral sclerosis	0.0011	0.00381	CbGeAlD
Thioridazine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.00109	0.00379	CbGeAlD
Thioridazine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00109	0.00379	CbGeAlD
Thioridazine—KCNH2—brain—amyotrophic lateral sclerosis	0.00108	0.00376	CbGeAlD
Thioridazine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00107	0.00373	CbGeAlD
Thioridazine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.00105	0.00365	CbGeAlD
Thioridazine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00105	0.00364	CbGeAlD
Thioridazine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00103	0.00356	CbGeAlD
Thioridazine—CYP2C8—brain—amyotrophic lateral sclerosis	0.00099	0.00344	CbGeAlD
Thioridazine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000948	0.00329	CbGeAlD
Thioridazine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000913	0.00317	CbGeAlD
Thioridazine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000892	0.0031	CbGeAlD
Thioridazine—HRH1—brain—amyotrophic lateral sclerosis	0.000867	0.00301	CbGeAlD
Thioridazine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000863	0.003	CbGeAlD
Thioridazine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000852	0.00296	CbGeAlD
Thioridazine—CYP2E1—brain—amyotrophic lateral sclerosis	0.000834	0.00289	CbGeAlD
Thioridazine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000831	0.00289	CbGeAlD
Thioridazine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000813	0.00282	CbGeAlD
Thioridazine—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.000805	0.349	CrCbGaD
Thioridazine—HTR2A—brain—amyotrophic lateral sclerosis	0.000724	0.00252	CbGeAlD
Thioridazine—CYP2D6—brain—amyotrophic lateral sclerosis	0.00066	0.00229	CbGeAlD
Thioridazine—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.67e-05	0.000678	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.65e-05	0.00067	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.64e-05	0.000666	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	1.63e-05	0.000661	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.61e-05	0.000653	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.61e-05	0.000652	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.6e-05	0.00065	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.57e-05	0.000639	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.56e-05	0.000636	CbGpPWpGaD
Thioridazine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.56e-05	0.000632	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.55e-05	0.00063	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.54e-05	0.000625	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.52e-05	0.000618	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.52e-05	0.000618	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.51e-05	0.000615	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.51e-05	0.000613	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.51e-05	0.000612	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.51e-05	0.000612	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.5e-05	0.000608	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.49e-05	0.000607	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.49e-05	0.000606	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.49e-05	0.000605	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.49e-05	0.000604	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.48e-05	0.000602	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.47e-05	0.000597	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.46e-05	0.000595	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000588	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.000585	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.44e-05	0.000583	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.43e-05	0.000583	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000582	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.41e-05	0.000572	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.4e-05	0.000571	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.4e-05	0.000569	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.4e-05	0.000569	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.39e-05	0.000564	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.38e-05	0.000562	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.00056	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.38e-05	0.000559	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.36e-05	0.000553	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.35e-05	0.000548	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.34e-05	0.000545	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.3e-05	0.000527	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.29e-05	0.000525	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.29e-05	0.000525	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.28e-05	0.00052	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.28e-05	0.00052	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	0.00052	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.27e-05	0.000517	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.27e-05	0.000516	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000508	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000507	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.24e-05	0.000503	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.24e-05	0.000502	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.23e-05	0.000499	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000499	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.23e-05	0.000499	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.22e-05	0.000498	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.22e-05	0.000495	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.22e-05	0.000495	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.21e-05	0.000493	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.2e-05	0.000486	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.19e-05	0.000484	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.19e-05	0.000483	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.19e-05	0.000482	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.18e-05	0.000481	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000479	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.17e-05	0.000474	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.16e-05	0.000469	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000469	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.15e-05	0.000469	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.14e-05	0.000462	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.13e-05	0.00046	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.12e-05	0.000456	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.12e-05	0.000453	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.11e-05	0.000451	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.11e-05	0.00045	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.11e-05	0.000449	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.1e-05	0.000448	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.09e-05	0.000445	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.09e-05	0.000441	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.08e-05	0.00044	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.06e-05	0.000432	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.06e-05	0.000432	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.06e-05	0.000431	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.06e-05	0.00043	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.06e-05	0.00043	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.05e-05	0.000427	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.05e-05	0.000427	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.04e-05	0.000424	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.03e-05	0.000418	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.03e-05	0.000417	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.02e-05	0.000415	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.02e-05	0.000414	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.01e-05	0.000411	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.01e-05	0.00041	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.01e-05	0.000409	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.01e-05	0.000409	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.96e-06	0.000405	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.95e-06	0.000404	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.8e-06	0.000398	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.64e-06	0.000392	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.62e-06	0.000391	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.59e-06	0.00039	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.51e-06	0.000386	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.5e-06	0.000386	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.46e-06	0.000385	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.44e-06	0.000383	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.35e-06	0.00038	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.33e-06	0.000379	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.18e-06	0.000373	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.16e-06	0.000372	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.1e-06	0.00037	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.05e-06	0.000368	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.01e-06	0.000366	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.99e-06	0.000365	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.98e-06	0.000365	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	8.8e-06	0.000358	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.79e-06	0.000357	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.77e-06	0.000356	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.75e-06	0.000355	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.66e-06	0.000352	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.55e-06	0.000347	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.51e-06	0.000346	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.35e-06	0.000339	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.2e-06	0.000333	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.18e-06	0.000332	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.14e-06	0.000331	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.08e-06	0.000328	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.04e-06	0.000327	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.03e-06	0.000326	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.99e-06	0.000324	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.86e-06	0.000319	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.85e-06	0.000319	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.85e-06	0.000319	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.84e-06	0.000319	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.72e-06	0.000313	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.69e-06	0.000313	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.56e-06	0.000307	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.52e-06	0.000306	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.51e-06	0.000305	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.39e-06	0.0003	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.38e-06	0.0003	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.37e-06	0.0003	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.25e-06	0.000295	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.23e-06	0.000294	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.21e-06	0.000293	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.2e-06	0.000292	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.15e-06	0.00029	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.04e-06	0.000286	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7e-06	0.000284	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.94e-06	0.000282	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.76e-06	0.000275	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.72e-06	0.000273	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.7e-06	0.000272	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	6.65e-06	0.00027	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.64e-06	0.00027	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	6.61e-06	0.000269	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.57e-06	0.000267	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.53e-06	0.000265	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.52e-06	0.000265	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.41e-06	0.00026	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.39e-06	0.00026	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.38e-06	0.000259	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.2e-06	0.000252	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.18e-06	0.000251	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.08e-06	0.000247	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	6.07e-06	0.000247	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.07e-06	0.000246	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.05e-06	0.000246	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.04e-06	0.000245	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.97e-06	0.000242	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.95e-06	0.000242	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.94e-06	0.000241	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.81e-06	0.000236	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.78e-06	0.000235	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.71e-06	0.000232	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.71e-06	0.000232	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.7e-06	0.000232	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.69e-06	0.000231	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.65e-06	0.00023	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.62e-06	0.000228	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.54e-06	0.000225	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.53e-06	0.000225	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	5.25e-06	0.000213	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.24e-06	0.000213	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.2e-06	0.000211	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.19e-06	0.000211	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.13e-06	0.000208	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.12e-06	0.000208	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.1e-06	0.000207	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.02e-06	0.000204	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.01e-06	0.000204	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.93e-06	0.0002	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.92e-06	0.0002	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.92e-06	0.0002	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.83e-06	0.000196	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	4.69e-06	0.00019	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.57e-06	0.000186	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.53e-06	0.000184	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.48e-06	0.000182	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.45e-06	0.000181	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.44e-06	0.00018	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.42e-06	0.000179	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.31e-06	0.000175	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.27e-06	0.000174	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.26e-06	0.000173	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.23e-06	0.000172	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.21e-06	0.000171	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.16e-06	0.000169	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.03e-06	0.000164	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.93e-06	0.00016	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.88e-06	0.000158	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.87e-06	0.000157	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.87e-06	0.000157	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.86e-06	0.000157	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.8e-06	0.000154	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.8e-06	0.000154	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.79e-06	0.000154	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.78e-06	0.000154	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.71e-06	0.000151	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.65e-06	0.000148	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.65e-06	0.000148	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.65e-06	0.000148	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.62e-06	0.000147	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.6e-06	0.000146	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.59e-06	0.000146	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.58e-06	0.000145	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.52e-06	0.000143	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.34e-06	0.000136	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.33e-06	0.000135	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.32e-06	0.000135	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.28e-06	0.000133	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.27e-06	0.000133	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.22e-06	0.000131	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.21e-06	0.000131	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.21e-06	0.00013	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.98e-06	0.000121	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.95e-06	0.00012	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.93e-06	0.000119	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.87e-06	0.000117	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.85e-06	0.000116	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.73e-06	0.000111	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.52e-06	0.000102	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.5e-06	0.000102	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.48e-06	0.000101	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.47e-06	0.000101	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.43e-06	9.89e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.43e-06	9.86e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.26e-06	9.16e-05	CbGpPWpGaD
